Antemortem detection of Parkinson's disease pathology in peripheral biopsies using artificial intelligence
- PMID: 35164870
- PMCID: PMC8842941
- DOI: 10.1186/s40478-022-01318-7
Antemortem detection of Parkinson's disease pathology in peripheral biopsies using artificial intelligence
Abstract
The diagnosis of Parkinson's disease (PD) is challenging at all stages due to variable symptomatology, comorbidities, and mimicking conditions. Postmortem assessment remains the gold standard for a definitive diagnosis. While it is well recognized that PD manifests pathologically in the central nervous system with aggregation of α-synuclein as Lewy bodies and neurites, similar Lewy-type synucleinopathy (LTS) is additionally found in the peripheral nervous system that may be useful as an antemortem biomarker. We have previously found that detection of LTS in submandibular gland (SMG) biopsies is sensitive and specific for advanced PD; however, the sensitivity is suboptimal especially for early-stage disease. Further, visual microscopic assessment of biopsies by a neuropathologist to identify LTS is impractical for large-scale adoption. Here, we trained and validated a convolutional neural network (CNN) for detection of LTS on 283 digital whole slide images (WSI) from 95 unique SMG biopsies. A total of 8,450 LTS and 35,066 background objects were annotated following an inter-rater reliability study with Fleiss Kappa = 0.72. We used transfer learning to train a CNN model to classify image patches (151 × 151 pixels at 20× magnification) with and without the presence of LTS objects. The trained CNN model showed the following performance on image patches: sensitivity: 0.99, specificity: 0.99, precision: 0.81, accuracy: 0.99, and F-1 score: 0.89. We further tested the trained network on 1230 naïve WSI from the same cohort of research subjects comprising 42 PD patients and 14 controls. Logistic regression models trained on features engineered from the CNN predictions on the WSI resulted in sensitivity: 0.71, specificity: 0.65, precision: 0.86, accuracy: 0.69, and F-1 score: 0.76 in predicting clinical PD status, and 0.64 accuracy in predicting PD stage, outperforming expert neuropathologist LTS density scoring in terms of sensitivity but not specificity. These findings demonstrate the practical utility of a CNN detector in screening for LTS, which can translate into a computational tool to facilitate the antemortem tissue-based diagnosis of PD in clinical settings.
Keywords: Artificial intelligence; Convolutional neural network; Deep learning; Machine learning; Parkinson’s disease; Peripheral biopsy; Submandibular gland; Synucleinopathy; Whole slide image.
© 2022. The Author(s).
Conflict of interest statement
Bahram Marami, Marcel Prastawa, Mary Sawyer, Israel Duran, John Koll, Gerardo Fernandez, Jack Zeineh, and Carlos Cordon-Cardo disclose their relationship with PreciseDx™, an artificial intelligence-guided pathology diagnostics company, which has developed proprietary platform and AI algorithms used in this study.
Figures





Similar articles
-
Submandibular gland is a suitable site for alpha synuclein pathology in Parkinson disease.Parkinsonism Relat Disord. 2019 Jan;58:35-39. doi: 10.1016/j.parkreldis.2018.04.019. Epub 2018 Apr 19. Parkinsonism Relat Disord. 2019. PMID: 30340912
-
Prevalence of Submandibular Gland Synucleinopathy in Parkinson's Disease, Dementia with Lewy Bodies and other Lewy Body Disorders.J Parkinsons Dis. 2016;6(1):153-63. doi: 10.3233/JPD-150680. J Parkinsons Dis. 2016. PMID: 26756744 Free PMC article.
-
α-Synuclein real-time quaking-induced conversion in the submandibular glands of Parkinson's disease patients.Mov Disord. 2020 Feb;35(2):268-278. doi: 10.1002/mds.27907. Epub 2019 Nov 23. Mov Disord. 2020. PMID: 31758740 Free PMC article.
-
The Search for a Peripheral Biopsy Indicator of α-Synuclein Pathology for Parkinson Disease.J Neuropathol Exp Neurol. 2017 Jan 1;76(1):2-15. doi: 10.1093/jnen/nlw103. J Neuropathol Exp Neurol. 2017. PMID: 28069931 Review.
-
Alpha-synuclein in salivary gland as biomarker for Parkinson's disease.Rev Neurosci. 2019 Jul 26;30(5):455-462. doi: 10.1515/revneuro-2018-0064. Rev Neurosci. 2019. PMID: 30471223
Cited by
-
Artificial intelligence-derived neurofibrillary tangle burden is associated with antemortem cognitive impairment.Acta Neuropathol Commun. 2022 Oct 31;10(1):157. doi: 10.1186/s40478-022-01457-x. Acta Neuropathol Commun. 2022. PMID: 36316708 Free PMC article.
-
The status of digital pathology and associated infrastructure within Alzheimer's Disease Centers.J Neuropathol Exp Neurol. 2023 Feb 21;82(3):202-211. doi: 10.1093/jnen/nlac127. J Neuropathol Exp Neurol. 2023. PMID: 36692179 Free PMC article.
-
Hybrid preprocessing and ensemble classification for enhanced detection of Parkinson's disease using multiple speech signal databases.Digit Health. 2025 Jun 26;11:20552076251352941. doi: 10.1177/20552076251352941. eCollection 2025 Jan-Dec. Digit Health. 2025. PMID: 40585053 Free PMC article.
-
Diagnostic Efficacy and Clinical Relevance of Artificial Intelligence in Detecting Cognitive Decline.Cureus. 2023 Oct 13;15(10):e47004. doi: 10.7759/cureus.47004. eCollection 2023 Oct. Cureus. 2023. PMID: 37965412 Free PMC article. Review.
-
Artificial Intelligence Models in the Diagnosis of Adult-Onset Dementia Disorders: A Review.Bioengineering (Basel). 2022 Aug 5;9(8):370. doi: 10.3390/bioengineering9080370. Bioengineering (Basel). 2022. PMID: 36004895 Free PMC article. Review.
References
-
- (2016) Systemic synuclein sampling study s4: biospecimen collection, processing, and shipment manual. https://michaeljfox.Org/Files/S4_Biologics_Manual_Version_2.Pdf
-
- Adler CH, Beach TG, Hentz JG, Shill HA, Caviness JN, Driver-Dunckley E, Sabbagh MN, Sue LI, Jacobson SA, Belden CM, et al. Low clinical diagnostic accuracy of early vs advanced Parkinson disease: clinicopathologic study. Neurology. 2014;83:406–412. doi: 10.1212/Wnl.0000000000000641. - DOI - PMC - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical